January 2019 - Page 318 of 431

NYSE Companies - January 9, 2019

Rafael Pharmaceuticals Announces Initiation of Phase II Trial of CPI-613 in Combination with Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer

Newark, NJ, Jan. 09, 2019 (GLOBE NEWSWIRE) — Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based […]

NYSE Companies - January 9, 2019

Brunswick Reports More Than 125 Patents Granted in 2018; Up Nearly a Third Year-Over-Year

METTAWA, Ill., Jan. 09, 2019 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) today announced that it had 126 United States […]

NASDAQ Companies - January 9, 2019

First Western Financial, Inc. to Report Fourth Quarter 2018 Financial Results

DENVER, Jan. 09, 2019 (GLOBE NEWSWIRE) — First Western Financial, Inc. (NASDAQ: MYFW), a financial services holding company headquartered in […]

NASDAQ Companies - January 9, 2019

Aqua Metals Promotes Steve Cotton to Chief Executive Officer

Cotton also Appointed to the Company’s Board of Directors MCCARRAN, Nev., Jan. 09, 2019 (GLOBE NEWSWIRE) — Aqua Metals, Inc. […]

NASDAQ Companies - January 9, 2019

Verona Pharma Receives WHO Approval for “ensifentrine” as Recommended INN for RPL554

Assignment of the “-fentrine” stem in the INN attests to RPL554’s dual phosphodiesterase inhibitor mechanism of action LONDON, Jan. 09, […]

NASDAQ Companies - January 9, 2019

LifeVantage Reports Record Second Quarter Preliminary Revenue

Q2 preliminary revenue of approximately $58 million represents the highest quarterly revenue in the company’s history Revenue increased approximately 17% […]

NASDAQ Companies - January 9, 2019

MarketAxess to Host Conference Call Announcing Fourth Quarter 2018 and Full Year Results on Wednesday, January 30, 2019

NEW YORK, Jan. 09, 2019 (GLOBE NEWSWIRE) — MarketAxess Holdings Inc. (Nasdaq: MKTX), the operator of a leading electronic trading […]

NASDAQ Companies - January 9, 2019

Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services

Executive appointment underscores continued execution of new corporate strategy of expanding Biopharma and Discovery businesses RUTHERFORD, N.J. and RESEARCH TRIANGLE […]

NASDAQ Companies - January 9, 2019

CareDx to Present New AlloSure® Data at American Society of Transplant Surgeons Winter Symposium

AlloSure utility studied in patients with delayed graft function BRISBANE, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), […]

NASDAQ Companies - January 9, 2019

Pluristem Therapeutics Reports Successful Case Study in Treatment of Buerger’s Disease Patient

Buerger’s disease is a severe vascular inflammatory disease associated with high risk of amputation Patient was at a pre-amputation stage […]